Critical Care

official impact factor 4.60

Download references

Open Access

Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected ICU-acquired candidemia among patients with sepsis: a model simulation

Marya D Zilberberg*, Smita Kothari and Andrew F Shorr

Critical Care 2009, 13:R94 doi:10.1186/cc7924

Include


Format